Contact

[email protected]
+1 941 755 6644

Follow

Info

Welcome to the Archer Pharmaceuticals website! Use this panel to navigate all the pages of the site.

50 Million of people around the world are currently suffering from Alzheimer's disease - 5.5 million of them in the US. Archer Pharmaceuticals was formed in 2008 to advance drug therapies to slow or prevent the disease.
What's New?
See the latest announcements from Archer Pharma.

Read More

Find Us on Facebook!
New discoveries are just a few posts away.

To Facebook

Moving Innovation Forward

Archer's world-class team of researchers and scientists are, after extensive laboratory-based research, repurposing drugs (previously designed for use in hypertension) for Alzheimer's disease. This approach has been tested in human clinical trials and shows early promise in slowing or preventing the disease.
Alzheimer's Will Be Defeated.
Alzheimer’s disease is a growing problem around the world, with devastating consequences for patients, caregivers and families. As we understand more and more about the disease, it's clear it can be halted.
Nilvadipine. Clinical Trials.
Even modest therapeutic advances that delay Alzheimer’s Disease onset and progression could significantly reduce the global burden of the disease and the level of care required by patients. Want more information?
Subscribe to our newsletter to get the latest news on our work.